Grove Bank & Trust’s Twist Bioscience TWST Stock Holding History

Grove Bank & Trust’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-57	Closed	-$1.16K	–	708
2023 Q3	$1.16K	Buy	+57	New	+$1.25K	﹤0.01%	690

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grove Bank & Trust's TWST Position: Q4 2023 in Review

Grove Bank & Trust sold out of Twist Bioscience (TWST) in Q4 2023, closing a stake of 57 shares — an estimated $1.16K sold.

Grove Bank & Trust first reported a position in TWST in Q3 2023 and held it in 1 quarter. The position peaked at $1.16K in Q3 2023. 218 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

Grove Bank & Trust reported no remaining Twist Bioscience position as of Q4 2023 after selling out during the quarter.
Grove Bank & Trust sold 57 Twist Bioscience shares in Q4 2023, an estimated $1.16K.
Grove Bank & Trust first reported a position in Twist Bioscience in Q3 2023 and held it in 1 quarter.
Grove Bank & Trust's Twist Bioscience position peaked at $1.16K in Q3 2023.
218 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.